Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

ClinicalTrials.gov ID: NCT00277810

Public ClinicalTrials.gov record NCT00277810. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Safety, Tolerability, and Efficacy Study of 3 Doses of Lecozotan (SRA-333) SR in Outpatients With Mild to Moderate Alzheimer's Disease Treated With a Cholinesterase Inhibitor

Study identification

NCT ID
NCT00277810
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
250 participants

Conditions and interventions

Interventions

  • lecozotan SR (SRA-333) Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2006
Primary completion
May 31, 2008
Completion
May 31, 2008
Last update posted
Jul 6, 2020

2006 – 2008

United States locations

U.S. sites
33
U.S. states
14
U.S. cities
33
Facility City State ZIP Site status
Not listed Phoenix Arizona 85013
Not listed Tucson Arizona 85741
Not listed Costa Mesa California 92626
Not listed Fresno California 93720
Not listed La Jolla California 92037
Not listed Orange California 92868
Not listed Delray Beach Florida 33445
Not listed Fort Lauderdale Florida 33321
Not listed Fort Myers Florida 33916
Not listed Hallandale Florida 33009
Not listed Hialeah Florida 33016
Not listed Jacksonville Florida 33216
Not listed Miami Florida 33176
Not listed Miami Beach Florida 33154
Not listed Orlando Florida 32806
Not listed Sarasota Florida 34239
Not listed South Miami Florida 33143
Not listed Tampa Florida 33617
Not listed West Palm Beach Florida 33407
Not listed St Louis Missouri 63104
Not listed Long Branch New Jersey 07740
Not listed Manchester Twp. New Jersey 08759
Not listed Albany New York 12208
Not listed Cedarhurst New York 11516
Not listed Staten Island New York 10312
Not listed Winston-Salem North Carolina 27103
Not listed Columbus Ohio 43210
Not listed Tulsa Oklahoma 74104
Not listed Philadelphia Pennsylvania 19107
Not listed East Providence Rhode Island 02914
Not listed Memphis Tennessee 38119
Not listed Houston Texas 77030
Not listed Bennington Vermont 05201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00277810, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 6, 2020 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00277810 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →